METOPIRONE

This brand name is authorized in Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug METOPIRONE contains one active pharmaceutical ingredient (API):

1 Mepyrapone UNII ZS9KD92H6V - METYRAPONE

Read about Mepyrapone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
METOPIRONE Capsules	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V04CD01	Metyrapone	V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CD Tests for pituitary function
Discover more medicines within V04CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1688564
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 79004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 573647
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 40384
Country: HK	Department of Health Drug Office	Identifier(s): 19150
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-943646664
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 563
Country: JP	医薬品医療機器総合機構	Identifier(s): 7223001M1035
Country: MT	Medicines Authority	Identifier(s): AA565/18302, AA565/18304, AA883/00101
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1805
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3031
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100323786
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66831001